Healthcare Innovation
Roche, Hansoh Partner to Develop Cancer-Targeted ADCs
Roche and Hansoh Pharma partner to develop antibody-drug conjugates targeting cancer, with a $400 million upfront investment.
Roche and Hansoh Pharma partner to develop antibody-drug conjugates targeting cancer, with a $400 million upfront investment.
© 2026 Healthy Waukesha . All rights reserved.
Powered by WordPress & Core Web Vitals Ultra-Fast Engine